Canada markets closed

NeuroOne Medical Technologies Corporation (NMTC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.38000.0000 (0.00%)
At close: 03:59PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.67
52-Week Change 3-29.23%
S&P500 52-Week Change 3-10.08%
52 Week High 33.1800
52 Week Low 30.5100
50-Day Moving Average 31.5438
200-Day Moving Average 31.3478

Share Statistics

Avg Vol (3 month) 3296.46k
Avg Vol (10 day) 369.89k
Shares Outstanding 516.24M
Implied Shares Outstanding 6N/A
Float 812.37M
% Held by Insiders 116.32%
% Held by Institutions 112.35%
Shares Short (Jan 12, 2023) 4276.59k
Short Ratio (Jan 12, 2023) 41.86
Short % of Float (Jan 12, 2023) 41.79%
Short % of Shares Outstanding (Jan 12, 2023) 41.70%
Shares Short (prior month Dec 14, 2022) 4494.68k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:3
Last Split Date 3Mar 31, 2021

Financial Highlights

Fiscal Year

Fiscal Year Ends Sept 29, 2022
Most Recent Quarter (mrq)Sept 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-473.14%

Management Effectiveness

Return on Assets (ttm)-60.39%
Return on Equity (ttm)-123.77%

Income Statement

Revenue (ttm)2.12M
Revenue Per Share (ttm)0.13
Quarterly Revenue Growth (yoy)3,672.80%
Gross Profit (ttm)-3.05M
EBITDA -9.91M
Net Income Avi to Common (ttm)-10M
Diluted EPS (ttm)-0.8250
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)11.14M
Total Cash Per Share (mrq)0.69
Total Debt (mrq)202.9k
Total Debt/Equity (mrq)2.11
Current Ratio (mrq)3.93
Book Value Per Share (mrq)0.59

Cash Flow Statement

Operating Cash Flow (ttm)-7.52M
Levered Free Cash Flow (ttm)-4.18M